A carregar...
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
BACKGROUND: The endocannabinoids system (ECs) mediated mainly by CB1 and CB2 receptors plays an important role in non-alcoholic fatty liver disease by regulating lipid metabolism. This study is to further investigate the expression of CB1 and CB2 in the fat accumulation liver cells and to identify p...
Na minha lista:
| Publicado no: | Lipids Health Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4247673/ https://ncbi.nlm.nih.gov/pubmed/25406988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-13-173 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|